09:17 AM EDT, 05/20/2026 (MT Newswires) -- Healthcare stocks were edging higher premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) up 0.3% and the iShares Biotechnology ETF (IBB) advancing by 0.8%.

Roivant Sciences ( ROIV ) stock was up nearly 6% after the company reported that it swung to a fiscal Q4 net income.

ImmunityBio's ( IBRX ) supplemental biologics license application for Anktiva in combination with Bacillus Calmette-Guerin in patients with bladder cancer with papillary disease has been accepted for review by the US Food and Drug Administration, the company said. ImmunityBio ( IBRX ) shares were 8% higher pre-bell.

Natera ( NTRA ) stock was up more than 2% after the company said the trial evaluating its Fetal Focus single-gene noninvasive prenatal test has enrolled more than 2,000 patients, more than doubling enrollment over the past year.